Oppenheimer & Co. Inc. Has $11.62 Million Position in Encompass Health Corporation $EHC

Oppenheimer & Co. Inc. lessened its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 7.0% in the third quarter, HoldingsChannel.com reports. The firm owned 91,497 shares of the company’s stock after selling 6,917 shares during the period. Oppenheimer & Co. Inc.’s holdings in Encompass Health were worth $11,622,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in EHC. Citizens National Bank Trust Department acquired a new position in shares of Encompass Health during the third quarter valued at about $26,000. First Horizon Corp acquired a new stake in shares of Encompass Health in the 3rd quarter worth about $34,000. Westside Investment Management Inc. lifted its position in Encompass Health by 56.7% in the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after acquiring an additional 101 shares in the last quarter. Root Financial Partners LLC acquired a new position in Encompass Health during the 3rd quarter valued at about $39,000. Finally, Newbridge Financial Services Group Inc. increased its holdings in Encompass Health by 112.5% during the 2nd quarter. Newbridge Financial Services Group Inc. now owns 425 shares of the company’s stock worth $52,000 after purchasing an additional 225 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Encompass Health Stock Up 0.9%

EHC stock opened at $106.33 on Tuesday. The stock has a market cap of $10.70 billion, a P/E ratio of 19.19, a P/E/G ratio of 1.66 and a beta of 0.73. The company has a current ratio of 1.08, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76. The stock’s fifty day simple moving average is $104.09 and its two-hundred day simple moving average is $114.49. Encompass Health Corporation has a 1-year low of $92.53 and a 1-year high of $127.99.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.29 by $0.17. The firm had revenue of $3.09 billion during the quarter, compared to analyst estimates of $1.54 billion. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The business’s revenue was up 9.9% compared to the same quarter last year. During the same period last year, the firm posted $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Barclays raised their target price on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a report on Friday. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Finally, Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $143.29.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.